MARTONE, RAFFAELE
 Distribuzione geografica
Continente #
NA - Nord America 869
EU - Europa 756
AS - Asia 143
AF - Africa 4
OC - Oceania 3
Totale 1.775
Nazione #
US - Stati Uniti d'America 866
RU - Federazione Russa 308
PL - Polonia 220
SE - Svezia 72
IE - Irlanda 69
IT - Italia 67
SG - Singapore 50
HK - Hong Kong 32
CN - Cina 21
JO - Giordania 17
IN - India 10
GB - Regno Unito 9
VN - Vietnam 8
DE - Germania 7
AU - Australia 3
CA - Canada 3
CI - Costa d'Avorio 3
PH - Filippine 3
CH - Svizzera 2
PK - Pakistan 2
FI - Finlandia 1
MU - Mauritius 1
NL - Olanda 1
Totale 1.775
Città #
Warsaw 220
Santa Clara 204
Fairfield 111
Dublin 67
Ashburn 56
Houston 46
Chandler 45
Woodbridge 43
Singapore 41
Wilmington 33
Lawrence 28
Moscow 28
Seattle 27
Altamura 26
Cambridge 25
Hong Kong 19
Ann Arbor 15
Buffalo 15
Princeton 15
Florence 12
San Diego 12
Shanghai 11
Boston 10
Medford 10
Dong Ket 8
Mumbai 7
New York 6
London 5
Cagliari 4
Falls Church 4
Milan 4
Abidjan 3
Manila 3
Norwalk 3
Phoenix 3
Redmond 3
Beijing 2
Bern 2
Brossard 2
Falkenstein 2
Fort Worth 2
Karachi 2
Los Angeles 2
Naples 2
Padova 2
Redwood City 2
Sydney 2
Trieste 2
Washington 2
Yubileyny 2
Andover 1
Arezzo 1
Bhubaneswar 1
Boardman 1
Boise 1
Brisbane 1
Bussolengo 1
Ferrara di Monte Baldo 1
Fremont 1
Helsinki 1
Hillsboro 1
Islington 1
Kent 1
Kilburn 1
Kolkata 1
Lancaster 1
Nagold 1
Pesaro 1
Prescot 1
Prineville 1
Pune 1
Rui'an 1
Shenzhen 1
Springfield 1
Toronto 1
Totale 1.225
Nome #
Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon 209
Semi-quantitative indices of cardiac uptake in patients with suspected cardiac amyloidosis undergoing 99mTc-HMDP scintigraphy 190
Heart failure with mid-range ejection fraction: Current evidence and uncertainties 159
Electromechanical dissociation of left atrium in patients with Cardiac Amyloidosis by Magnetic Resonance: Prognostic and clinical correlates 106
Epigallocatechin-3-gallate tolerability and impact on survival in a cohort of patients with transthyretin-related cardiac amyloidosis. A single-center retrospective study 106
Poor right ventricular function is associated with impaired exercise capacity and ventilatory efficiency in transthyretin cardiac amyloid patients 101
Impact of complete percutaneous revascularization in elderly patients with chronic total occlusion 97
Baseline ECG features and arrhythmic profile in transthyretin versus light chain cardiac amyloidosis 96
ECG abnormalities, atrial fibrillation and AV blocks in ATTR VS AL amyloidosis: an electrophysiological natural history 92
Biomarkers and Prediction of Prognosis in Transthyretin-Related Cardiac Amyloidosis: Direct Comparison of Two Staging Systems 92
Echocardiographic phenotype and prognosis in transthyretin cardiac amyloidosis 91
A Man in His 80s with Hypertension, Left Ventricular Hypertrophy, and Enlarged Biceps 89
Cardiac amyloidosis in patient undergoing TAVR, why we need to think about it 79
Chest pain and mild left ventricular hypertrophy: a challenging diagnosis 79
Predicting atrial fibrillation in ATTR cardiac amyloidosis by mean of left atrial strain indexes 78
Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype 77
Clinical Importance of Left Atrial Infiltration in Cardiac Transthyretin Amyloidosis 61
Totale 1.802
Categoria #
all - tutte 5.241
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.241


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020197 0 0 0 0 31 30 33 34 28 15 20 6
2020/2021236 10 21 2 50 32 13 11 20 25 28 11 13
2021/2022151 3 5 5 9 6 7 1 12 8 25 18 52
2022/2023329 18 80 26 8 11 55 49 9 39 11 13 10
2023/2024151 2 19 21 6 11 17 11 32 6 17 6 3
2024/2025628 43 106 59 173 247 0 0 0 0 0 0 0
Totale 1.802